Your wife mentioned a telehealth platform where you could get your testosterone checked and treated online. Your friend swears by his GLP-1 prescription from a service he found through Instagram. And your reaction is skepticism — which, frankly, is the right starting position. Online medicine has earned both its enthusiasts and its skeptics for legitimate reasons.
Here's the case for and against, grounded in evidence rather than marketing or cynicism.
What the Evidence Supports About Telehealth
Diagnostic Accuracy
For conditions diagnosed primarily through lab work and symptom assessment — which includes hypogonadism, metabolic obesity, ED, and hair loss — telehealth diagnostic accuracy is essentially equivalent to in-person care. A testosterone level is a testosterone level whether the doctor reviewing it is across a desk or across a screen.
A 2023 systematic review in JAMA Network Open found that telehealth and in-person care produced equivalent clinical outcomes for chronic disease management across multiple specialties. For men's health specifically, the diagnostic workflow (labs + symptom questionnaire + video consultation) captures the same information as an in-person visit for these conditions.
Prescribing Standards
Legitimate telehealth platforms operate under the same prescribing regulations as in-person clinics. The prescribers are state-licensed physicians, physician assistants, or nurse practitioners with DEA registrations (required for testosterone). They must follow the same standard of care, including appropriate lab work before prescribing controlled substances.
The key qualifier: "legitimate" platforms. The telehealth landscape includes both well-regulated services with experienced clinicians and low-quality operations that prioritize prescription volume over clinical judgment. The regulatory framework is the same — the enforcement and self-governance vary.
Access and Convenience
For men who live in areas without men's health specialists, work schedules that make office visits difficult, or simply prefer the privacy of addressing sensitive health topics from home, telehealth removes real barriers to care. Research consistently shows that reduced access barriers increase the likelihood of men seeking treatment for conditions they would otherwise ignore.
Where Skepticism Is Warranted
The Prescription-First Model
Some telehealth platforms are built to prescribe, not to evaluate. The consultation is a formality; the business model assumes you'll get a prescription. This creates a bias toward treatment over watchful waiting, toward medication over lifestyle intervention, and toward adding therapies rather than subtracting them.
Red flags that a platform prioritizes prescriptions over clinical judgment:
- Consultation lasts under 5 minutes with no meaningful clinical discussion
- Lab work is optional or not required before prescribing
- The platform doesn't document a reason for prescribing beyond "patient requested"
- Follow-up visits are optional or cursory
- The platform has no mechanism for denying prescriptions to unsuitable candidates
The Physical Exam Gap
Telehealth can't perform a prostate exam, palpate thyroid nodules, assess testicular size, or evaluate gynecomastia. For most men seeking GLP-1s or ED medication, these physical findings aren't decision-drivers. For TRT candidates, a physical exam has more relevance — testicular atrophy, for example, provides diagnostic information about the type and duration of hypogonadism.
The practical solution: many telehealth platforms now require or encourage an in-person physical with a local provider as part of the initial workup. This hybrid model captures the convenience of telehealth with the diagnostic value of physical examination.
Continuity of Care
In-person practices build long-term physician-patient relationships. Some telehealth platforms assign a different clinician at every visit. The continuity difference matters most for complex cases — men on multi-medication regimens who need a clinician who remembers their history, understands their goals, and has context for clinical decisions.
The Quality Evaluation Checklist
How to Evaluate a Telehealth Platform
- Prescriber credentials: Can you verify their medical license and DEA registration? Are they experienced in the specific condition you're seeking treatment for?
- Lab requirements: Does the platform require bloodwork before prescribing? Do they specify which labs and how they'll be interpreted?
- Consultation quality: Is there a meaningful clinical conversation, or is it a rubber-stamp questionnaire?
- Follow-up protocol: How often are follow-up labs and consultations scheduled? Is there a protocol for dose adjustments?
- Pharmacy quality: Which pharmacy fills the prescriptions? Is it accredited? Do they provide batch testing results?
- Cancellation policy: Can you stop service without penalties? How do they handle prescription transfers?
The Bottom Line
Skepticism Is Smart — Blanket Rejection Isn't
Telehealth prescribing for men's health conditions is legitimate, evidence-supported, and in many cases clinically equivalent to in-person care. But the quality range across platforms is wide. A skeptical evaluation of a specific platform's clinical standards, prescriber qualifications, and lab protocols is exactly the right approach. The goal isn't to avoid telehealth — it's to distinguish the good platforms from the prescription mills.